Prostate cancer test
Prostate Cancer
Prostate cancer is one of the most common cancers in men. Many prostate cancers grow slowly and may never cause harm, while some are aggressive. Early prostate cancer usually causes no symptoms. Urinary symptoms such as a weak stream or getting up at night are more often caused by an enlarged prostate (BPH). Risk rises with age, and is higher in Black men and in men with a family history of prostate, breast or ovarian cancer or BRCA gene changes.
Lab tests linked to prostate cancer:
- PSA, % free: the share of PSA that circulates unbound. It is used mainly when total PSA is mildly raised, to help judge the chance of cancer.
- Doctors start with total PSA. They may add PSA density, other blood or urine markers, a prostate MRI, and a biopsy to confirm cancer.
How results are read:
- A raised total PSA has many causes: an enlarged prostate, prostatitis, recent ejaculation, and recent procedures. It doesn't diagnose cancer.
- When total PSA is mildly raised, a lower % free PSA is linked to a higher chance of cancer, and a higher % free PSA to a lower chance.
- Medicines such as finasteride and dutasteride lower PSA, so results are adjusted when men take them.
- An MRI before biopsy helps target suspicious areas and avoid unnecessary biopsies.
When to see a doctor:
- Talk to a doctor about the pros and cons of PSA screening, usually from your 50s, or earlier if you are Black or have a strong family history.
- See a doctor about blood in the urine or semen, new bone pain, or difficulty passing urine.
- Get emergency care if you can't pass urine at all.
Clinical takeaway: prostate cancer screening starts with total PSA, % free PSA helps refine the risk when PSA is borderline, and MRI and biopsy confirm the diagnosis.
Biomarkers related to this condition
2 markers linked to this condition
Prostate cancer risk refinement
Looking for a different marker? Browse all biomarkers →